ArticleJournal of cancer research and clinical oncology2016

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Hyori Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.